Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Teladoc (TDOC) shares are climbing on Thursday after the healthcare company announced ... of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback